Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention
1Department of Pediatrics, Division of Pediatric Endocrinology, University of Virginia School of Medicine, PO Box 800386, Charlottesville, VA 22908, USA Tel.: +1 434 924 9833 deboer@virginia.edu.
Insights
Pediatric obesity presents unique challenges across ethnic groups, particularly for African-American and Hispanic children who face higher risks for metabolic syndrome and Type 2 diabetes. Current diagnostic criteria may underestimate risks in these populations, necessitating ethnicity-inclusive approaches for effective intervention.
Area of Science:
- Pediatric endocrinology
- Public health
- Metabolic disorders
Background:
- Pediatric obesity is a growing global health concern with long-term implications.
- Metabolic syndrome and its associated risks, like insulin resistance, manifest differently across ethnic groups.
- African-American and Hispanic adolescents exhibit higher risks for obesity and Type 2 diabetes.
Purpose of the Study:
- To highlight the challenges in identifying pediatric obesity risks due to ethnic variations in metabolic syndrome presentation.
- To emphasize the need for ethnicity-inclusive diagnostic criteria for metabolic syndrome in adolescents.
- To advocate for targeted interventions for at-risk children.
Main Methods:
- Review of current diagnostic criteria for pediatric metabolic syndrome.
- Analysis of ethnic disparities in obesity and metabolic syndrome prevalence.
- Examination of factors contributing to underdiagnosis in specific ethnic groups, such as dyslipidemia rates.
Main Results:
- African-American and Hispanic adolescents are disproportionately affected by obesity and insulin resistance.
- Current metabolic syndrome criteria often underdiagnose risk in African-American adolescents due to lower rates of dyslipidemia.
- Significant ethnic variations exist in the manifestation of pediatric obesity and metabolic syndrome.
Conclusions:
- Ethnicity-specific approaches are crucial for accurate risk assessment in pediatric obesity.
- Development of inclusive diagnostic tools is needed to effectively target interventions.
- Improved risk identification and targeted treatments can mitigate long-term health consequences of pediatric obesity across all ethnicities.
Abstract:
Pediatric obesity threatens the future health of a growing number of children worldwide. An added challenge in identifying the patients at greatest need for intervention due to their elevated risk for future disease is that pediatric obesity and the associated metabolic syndrome manifest differently among different ethnic groups. African-Americans and Hispanics are more likely to exhibit obesity and insulin resistance and are at a higher risk for developing Type 2 diabetes. Nevertheless, using current criteria, African-American adolescents are much less likely to be diagnosed with metabolic syndrome, largely owing to lower rates of dyslipidemia. Further development is needed in ethnicity-inclusive means of risk identification among adolescents to accurately target treatment toward children at highest risk for future disease and to motivate adolescent patients and their families towards lifestyle improvement. Effective targeting and intensive treatment efforts may help in avoiding future sequelae of obesity among all ethnicities.
Related Concept Videos
Obesity
Type II Diabetes I: Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Cholesterol: Significance and Regulation
Considering cholesterol and...


